Study Evaluating Pyrotinib in Combination With Capecitabine In Patients With HER2 Positive Metastatic Breast Cancer
Clinical trial NCT02361112 · COMPLETED
Trial details
- NCT number
- NCT02361112
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2016-08-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.